pacing. The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and during stress induced atrial pacing in fourteen patients with chronic cardiac failure, secondary to coronary heart disease. Felodipine was an effective arteriolar vasodilator producing increases in cardiac index from 2-6 + 0'l to 3-5±0-2lmin~1 m~2 (P<0001) and stroke volume 35-3 ±2-7 to 41-4 ±2-4 ml beat'1 m~2 (P<0-002). Coronary venous flow also increased significantly (126 + 8 to 168+13mlmin~l) (P<0-005) andthisdid not appear to be accompanied by an increase in myocardial oxygen usage, as myocardial oxygen con-sumption was essentially unchanged. When the myocardium was stressed by atrial pacing the increase in cardiac output ...
Many drugs have recently been introduced for the treatment of hypertension and heart failure. These...
PubMed ID: 8879601The aim of the study was to evaluate the efficacy over 1 year of felodipine ER 5 a...
First-generation calcium antagonists have been used in patients with congestive heart failure with r...
In 13 patients with congestive heart failure we tested the acute hemodynamic effects of 5 vs. 10 mg ...
Chapter 1 offers an introduction in which the place of vasodilator therapy in heart failure is descr...
To assess whether the administration of felodipine protects the myocardium in a dose-dependent manne...
In a randomized, parallel, double‐blind study felodipine was administered to 11 and placebo to 12 pa...
Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federati...
In congestive heart failure patients the kinetics of felodipine, a dihydropyridine calcium antagonis...
We evaluated the cardiopulmonary exercise test results before and after long-term (16 weeks) treatme...
Felodipine (FEL) is a vasoselective dihydropyridine calcium antagonist that has shown promising resu...
Angiotensin-converting enzyme (ACE) inhibition is currently the cornerstone of congestive heart fail...
To investigate the antiischemic efficacy and duration of action of the dihydropyridine calcium antag...
textabstractThe effects of intravenous elgodipine, a new second-generation dihydropyridine calcium a...
First-generation calcium antagonists have been used in patients with congestive heart failure with r...
Many drugs have recently been introduced for the treatment of hypertension and heart failure. These...
PubMed ID: 8879601The aim of the study was to evaluate the efficacy over 1 year of felodipine ER 5 a...
First-generation calcium antagonists have been used in patients with congestive heart failure with r...
In 13 patients with congestive heart failure we tested the acute hemodynamic effects of 5 vs. 10 mg ...
Chapter 1 offers an introduction in which the place of vasodilator therapy in heart failure is descr...
To assess whether the administration of felodipine protects the myocardium in a dose-dependent manne...
In a randomized, parallel, double‐blind study felodipine was administered to 11 and placebo to 12 pa...
Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federati...
In congestive heart failure patients the kinetics of felodipine, a dihydropyridine calcium antagonis...
We evaluated the cardiopulmonary exercise test results before and after long-term (16 weeks) treatme...
Felodipine (FEL) is a vasoselective dihydropyridine calcium antagonist that has shown promising resu...
Angiotensin-converting enzyme (ACE) inhibition is currently the cornerstone of congestive heart fail...
To investigate the antiischemic efficacy and duration of action of the dihydropyridine calcium antag...
textabstractThe effects of intravenous elgodipine, a new second-generation dihydropyridine calcium a...
First-generation calcium antagonists have been used in patients with congestive heart failure with r...
Many drugs have recently been introduced for the treatment of hypertension and heart failure. These...
PubMed ID: 8879601The aim of the study was to evaluate the efficacy over 1 year of felodipine ER 5 a...
First-generation calcium antagonists have been used in patients with congestive heart failure with r...